From Surviving to Thriving: Navigating Menopause with Microdosing

Join us for an illuminating conversation on how microdosing may support women through the transitions of perimenopause and menopause. In this session, we explore the relationship between hormones and the brain, the emerging science behind psychedelics and microdosing as a potential non-hormonal support option, and why it’s critical that women’s biology is centered in research, policy, and access.

Inside This Conversation

The Science of Hormones and the Brain
How changes in estrogen and progesterone during perimenopause and menopause affect mood, memory, sleep, and cognitive health, and why this stage of life needs far more attention in medical research.

Microdosing as a Supportive Tool
The emerging connection between psychedelics and estrogen pathways in the brain, and why microdosing is gaining attention as a potential non-hormonal option to support mood, neuroprotection, and mental clarity.

Real Stories from Women
Honest experiences from women navigating menopause who are exploring microdosing for resilience, emotional balance, and wellbeing.

Advocating for Better Data and Access
Why women have historically been excluded from clinical research, and how advocacy is pushing for more inclusive science, better data, and safe, legal access.

Speakers & Hosts

Dr. Grace Blest-Hopley

Founder & CEO of Hystelica

Marcella Hill

CEO & Author of WakeHerUp.co

Stephanie Karzon Abrams

Founder of Beyond Consulting
Research Director at Microdosing Collective
MSc Clinical Neuropharmacologist

Alli Schaper

Co-Founder of Microdosing Collective, Co-Founder of SuperMush, and Host of Into the Multiverse Podcast.

NEWSLETTER

Subscribe to THE DOSE and get the latest microdosing news, expert insights, legalization updates, and exclusive events—delivered straight to your inbox! 📩

Thank you! Check your email for confirmation.